Author

John Ashkenas

Observed name: Ashkenas, John

Institution: Taysha Gene Therapies (United States)

Observed institution: Taysha Gene Therapies (United States)

ORCID: 0000-0002-1773-3820

Observed ORCID: 0000-0002-1773-3820

OpenAlex ID: A5092587957

Physical and Pharmacokinetic Characterization of Soluvec™, a novel, solvent-free Aqueous Ivermectin Formulation

2023 · Richa Mandalaywala, Azhar Rana, et al. · Therapeutic Delivery · 8

rAAV9 vector biodistribution in nonhuman primate brain and spinal cord following lumbar intrathecal infusion

2026 · Emdadul Haque, Nino Devidze, et al. · Frontiers in Medicine · 1

Understanding Caregivers’ Experiences of Rett Syndrome: A Multinational Study of Symptoms and Meaningful Outcomes of Potential Treatments

2026 · Bruria Ben-Zeev, Elsa Rossignol, et al. · Neurology and Therapy

Works count: 4

Citation count: 9

H-index: 1

I10-index: